CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...